Individuals with a history of pulmonary, neurologic, hepatic, rheumatic, hematologic, or renal chronic disease, who were treated with immunosuppressive therapy in the 6 months prior to screening, or who used medication or supplements that may have confounded the study results were also excluded
Expert Opinion on Drug Metabolism & Toxicology, 16 (12), 11871198
What to watch for: At maintenance dose, the focus shifts from dose escalation to lifestyle optimization
Step 4: account for steady-state effects If you have been on tirzepatide for more than four weeks, you are at steady state
Overview With the discovery of acetyl-L-carnitine arginate, carnitines benefits have now